Supporting patients in the transition to the revised pexidartinib dosing regimen: perspectives from the multidisciplinary clinical and allied health professional team.

MLA

McCabe, Colleen, et al. “Supporting Patients in the Transition to the Revised Pexidartinib Dosing Regimen: Perspectives from the Multidisciplinary Clinical and Allied Health Professional Team.” Orphanet Journal of Rare Diseases, vol. 18, no. 1, Oct. 2023, p. 313. EBSCOhost, https://doi.org/10.1186/s13023-023-02926-9.

APA

McCabe, C., Wright, H., Polson, K., & Wagner, A. J. (2023). Supporting patients in the transition to the revised pexidartinib dosing regimen: perspectives from the multidisciplinary clinical and allied health professional team. Orphanet Journal of Rare Diseases, 18(1), 313. https://doi.org/10.1186/s13023-023-02926-9

Chicago

McCabe, Colleen, Hillary Wright, Kathleen Polson, and Andrew J Wagner. 2023. “Supporting Patients in the Transition to the Revised Pexidartinib Dosing Regimen: Perspectives from the Multidisciplinary Clinical and Allied Health Professional Team.” Orphanet Journal of Rare Diseases 18 (1): 313. doi:10.1186/s13023-023-02926-9.